News for 'Institute of Development Studies'

Oxford varsity enrols volunteers for Covid vaccine trial

Oxford varsity enrols volunteers for Covid vaccine trial

Rediff.com28 Mar 2020

The researchers, working in an 'unprecedented' vaccine development effort to prevent COVID-19, said they have started screening healthy volunteers (aged 18-55) from Friday for their upcoming trial in the Thames Valley Region of England.

Entry-level jobs no more easy to come by in formal sector

Entry-level jobs no more easy to come by in formal sector

Rediff.com11 Jul 2022

It is a trend that economists and researchers say might continue. The data shows the share of this age group in the net EPF accounts created - a proxy for net new formal jobs created - fell from 37.9 per cent in 2018-19 to 24.1 per cent in 2021-22.

'Coronavirus strain predominant in India originated in Europe'

'Coronavirus strain predominant in India originated in Europe'

Rediff.com3 Sep 2020

'Given that the globally most prevalent clade of SARS-CoV-2 is also predominant in India, any vaccine or drug that gets developed in the world should also prove effective in India'

Air pollution reducing life expectancy in India by 5 years

Air pollution reducing life expectancy in India by 5 years

Rediff.com14 Jun 2022

The residents of Delhi stand to lose 10 years of life expectancy if the current air pollution level persists.

Musk, The Blue Tick, Twitter's Future

Musk, The Blue Tick, Twitter's Future

Rediff.com18 Nov 2022

It would be ludicrous to expect Modi, Erdogan or Biden to pay to keep blue ticks on their respective official accounts. It would be equally ludicrous to expect the Delhi Metro or the Income Tax Department to pay, points out Devangshu Datta.

Who shouldn't take jab? Vaccine makers issue fact sheet

Who shouldn't take jab? Vaccine makers issue fact sheet

Rediff.com19 Jan 2021

The fact sheet also asked people to inform the vaccinator or a supervising official about their medical condition before taking the vaccine.

Bharat Biotech has two more Covid vaccines in pipeline

Bharat Biotech has two more Covid vaccines in pipeline

Rediff.com16 Jan 2021

First a scientist and then a businessman, founder chairman Krishna Ella quit his faculty position at the Medical University of South Carolina in Charleston, United States, in 1996 to return to India.

Biden picks Kashmiri-origin Sameera Fazili in WH team

Biden picks Kashmiri-origin Sameera Fazili in WH team

Rediff.com16 Jan 2021

In December, Aisha Shah was named as Partnerships Manager at the White House Office of Digital Strategy.

Dr Reddy's soft-launches Sputnik V in India at Rs 995 per dose

Dr Reddy's soft-launches Sputnik V in India at Rs 995 per dose

Rediff.com15 May 2021

Dr Reddy's Laboratories on Friday soft-launched imported COVID-19 vaccine Sputnik V, with Deepak Sapra, a senior executive of the drug-maker, taking the first shot in Hyderabad.

Make Your Network Your Net Worth

Make Your Network Your Net Worth

Rediff.com15 Nov 2022

'Who you know today will determine who you know tomorrow.' 'Becoming an expert in your domain will incentivise others to have you in their networks.' 'And the more diverse your network, the better it is.' An enlightening excerpt from Ambi Parmeswaran's All The World's A Stage: A Personal Branding Story.

Oxford COVID-19 vaccine promising, but...: Scientists

Oxford COVID-19 vaccine promising, but...: Scientists

Rediff.com21 Jul 2020

Doses of the vaccine were given to 1,077 healthy adults aged between 18 and 55 in five United Kingdom hospitals in April and May as part of the phase one clinical trial.

'Cyber attackers are 10 steps ahead'

'Cyber attackers are 10 steps ahead'

Rediff.com4 Apr 2023

'Hacking of an ID or an account will have the same impact on a user in a city and one in a small town.' 'Security is like a railroad, you create it to last for every customer.'

This path-breaking vaccine may win a Nobel, and it's for not Covid

This path-breaking vaccine may win a Nobel, and it's for not Covid

Rediff.com20 Oct 2021

The new malaria vaccine (RTS.S/ AS01, tentatively brand-named Mosquirix) is the very first one to offer immunity against a parasite -- specifically the plasmodium falciparum parasite, which is the deadliest of the five parasites that cause malaria.

Ahmedabad tops list of youngest realty buyers: Study

Ahmedabad tops list of youngest realty buyers: Study

Rediff.com19 May 2014

The index also highlighted price sensitivity among real estate buyers in Ahmedabad.

Hijab row: K'taka schools reopen on Monday, CM confident of peace

Hijab row: K'taka schools reopen on Monday, CM confident of peace

Rediff.com13 Feb 2022

He also said that a decision regarding reopening of pre-university and degree colleges will be taken after assessing the situation.

Top US doctor cautiously optimistic over COVID vaccine

Top US doctor cautiously optimistic over COVID vaccine

Rediff.com9 Jul 2020

There are a number of vaccine candidates already in clinical trial and a few out of those candidates have completed phase 1/2 status, he said, adding that there are trials that will be going into phase three sometime at the end of July and then others will follow in the months of August, September and October.

PM reviews preparations for vaccination against COVID-19

PM reviews preparations for vaccination against COVID-19

Rediff.com30 Jun 2020

The PM directed officials to evaluate various technology tools to ensure efficient and timely vaccination in due course of time. He also emphasised that detailed planning for such large scale vaccination should be undertaken immediately.

Ramdev's Patanjali claims to have COVID-19 medicine; Govt frowns

Ramdev's Patanjali claims to have COVID-19 medicine; Govt frowns

Rediff.com23 Jun 2020

While Ramdev claimed that Ayurved-based 'Coronil and Swasari' medicine have shown 100 per cent favourable results during clinical trials on COVID-19 infected patients except those on a life support system, the Ayush Ministry sought from the company detailed report on composition, testing and other data of the drugs.

Chanakya's TIPS to be a WINNER

Chanakya's TIPS to be a WINNER

Rediff.com7 Jan 2022

It is said in Chanakya Neeti that the grass on the ground survives the storm because it is flexible as per the direction of the wind. The large trees break down easily as they are strong and rigid. Winners are not rigid, they are flexible. At the same time, they are focused on winning. A must read excerpt from Radhakrishnan Pillai's Art Of Winning: The Chanakya Way.

Punjab has most obese women in India: Study

Punjab has most obese women in India: Study

Rediff.com22 Oct 2007

Where do you find the most obese women in the country? The answer is Punjab, according to a report by the government of India.

Govt panel recommends regular market approval for Covishield, Covaxin

Govt panel recommends regular market approval for Covishield, Covaxin

Rediff.com20 Jan 2022

An expert panel of India's central drug authority on Wednesday recommended granting regular market approval to COVID vaccines Covishield and Covaxin for use in adult population subject to certain conditions, official sources said.

New education policy aimed at making 'job creators': PM Modi

New education policy aimed at making 'job creators': PM Modi

Rediff.com1 Aug 2020

The role of the youth is very important in achieving the goal of 'ease of living' to give a better life to the poor, he told students.

SARS-CoV-2 alters lung cell metabolism: IIT Kharagpur

SARS-CoV-2 alters lung cell metabolism: IIT Kharagpur

Rediff.com14 Apr 2021

The research would lead to a better understanding of metabolic reprogramming and aid the development of better therapeutics to deal with the viral pandemics, an institute spokesperson said on Wednesday.

COVID-19 reinfection 'very rare': ICMR DG

COVID-19 reinfection 'very rare': ICMR DG

Rediff.com15 Sep 2020

The remarks come amid suspected cases of COVID-19 reinfection being reported from abroad and from Indian states like Telangana, Karnataka, Gujarat, Punjab and Maharashtra.

Govt panel recommends nod for phase 2/3 trials of Covovax on kids

Govt panel recommends nod for phase 2/3 trials of Covovax on kids

Rediff.com27 Jul 2021

An expert panel of India's Central Drug Authority on Tuesday recommended granting permission to Serum Institute of India (SII) for conducting phase 2/3 trials of Covid vaccine Covovax on children aged 2 to 17 years with certain conditions, official sources said.

Hijab row: Karnataka CM urges everyone not to make inciting statements

Hijab row: Karnataka CM urges everyone not to make inciting statements

Rediff.com10 Feb 2022

He will be holding a meeting with Ministers of Education and Home departments and officials later in the day aimed at taking certain measures to restore cordial and peaceful atmosphere and discipline at educational institutions.

Phase 3 trial of Oxford vaccine to begin in Pune from next week

Phase 3 trial of Oxford vaccine to begin in Pune from next week

Rediff.com19 Sep 2020

"The phase-III trial of 'Covishield' vaccine will begin at Sassoon hospital from next week. It is likely to start on Monday. Some volunteers have already come forward for the trial. "Around 150 to 200 volunteers will be administered the vaccine candidate dose," Dean of the state-run Sassoon General Hospital Dr Muralidhar Tambe said.

Does Siddha medicine have a Covid cure?

Does Siddha medicine have a Covid cure?

Rediff.com8 Aug 2020

'Not one single, but multiple trials are there to quote. However, these will be published as scientific manuscripts.' 'This includes integrative as well as standalone approaches in Covid mitigation.'

Now, 250 scholars slam PM Modi for rising intolerance

Now, 250 scholars slam PM Modi for rising intolerance

Rediff.com30 Oct 2015

A group of academics and scholars on Friday expressed their outrage and anger against the "assault on academic and constitutional freedom", joining the recent protests by writers, artistes, filmmakers, historians and scientists over "rising intolerance".

Continuous measures needed to curb pollution: SC tells govt, states

Continuous measures needed to curb pollution: SC tells govt, states

Rediff.com24 Nov 2021

The Supreme Court Wednesday asked the Centre and the NCR states to continue implementing for few days the measures to ensure improvement in air quality, saying that preventive actions are needed in anticipation to curb pollution even as it wondered what signals are being sent to the world.

PM Modi presents Suu Kyi copy of her research proposal

PM Modi presents Suu Kyi copy of her research proposal

Rediff.com6 Sep 2017

The gift is a special reproduction of the original research proposal she submitted for fellowship at Indian Institute of Advanced Study, Shimla in May 1986.

In the works: Priority list of who will get Covid vaccine first

In the works: Priority list of who will get Covid vaccine first

Rediff.com4 Sep 2020

The Centre has also contacted five domestic and three multinational vaccine makers to understand how soon a candidate vaccine against Covid-19 will be ready.

Scientists sceptical about Russia's COVID-19 vaccine

Scientists sceptical about Russia's COVID-19 vaccine

Rediff.com12 Aug 2020

Scientists around the world, including in India, suggest it hasn't been tested properly given the time constraint and there may not be enough evidence to prove its efficacy.

'Government doesn't believe unemployment is a problem'

'Government doesn't believe unemployment is a problem'

Rediff.com9 Feb 2022

'Unemployment barely figures in the Budget except as a derived demand from the industry and infrastructure.' 'There is no effort at direct attack on unemployment.'

US authorises Moderna vaccine for emergency use

US authorises Moderna vaccine for emergency use

Rediff.com19 Dec 2020

According to an official statement, the FDA has determined that the Moderna COVID-19 vaccine has met the statutory criteria for issuance of an emergency use authorisation (EUA).

India's Forever Debt To Bhabha, Sarabhai

India's Forever Debt To Bhabha, Sarabhai

Rediff.com22 Feb 2022

Dr Bhabha and Dr Sarabhai didn't feel guilty for their ambitions; it was for those 'mad scientists' that India is a powerhouse -- both at the atomic level and in the vastness of space, observes Kumar Abishek.

Why China Is Worried About Hong Kong

Why China Is Worried About Hong Kong

Rediff.com7 Apr 2022

'Although Hong Kong weathered many a storm and displayed a remarkable resilience to bounce back, the developments in the territory have raised question marks with regard to its future stability and prosperity.' A revealing excerpt from Rup Narayan Das's Hong Kong Conundrum: Pangs of Transition.

China claims traditional medicines fight COVID-19

China claims traditional medicines fight COVID-19

Rediff.com18 Apr 2020

Studies in China claim that traditional Chinese medicines seem to be working effectively on patients with mild or moderate symptoms of coronavirus.

Starbucks names Laxman Narasimhan as its new CEO

Starbucks names Laxman Narasimhan as its new CEO

Rediff.com2 Sep 2022

Laxman Narasimhan, a veteran in leading and advising global consumer-facing brands, has been named as the new CEO of coffee giant Starbucks, joining a growing cohort of Indian-origin business leaders at the helm of global corporations.

'We haven't heard the last about Omicron'

'We haven't heard the last about Omicron'

Rediff.com31 Dec 2021

'Your body will be able to deal with Omicron at any time, but it depends (on when) if you are vaccinated.'